ALR Technologies SG (ALRTF) Equity Ratio (2021 - 2025)

ALR Technologies SG posted quarterly Equity Ratio of 841.36 for Q4 2025, down 84.59% year-on-year from 5459.12 in Q4 2024, and up 31.96% on a QoQ basis from 1236.63 in Q2 2025.

ALR Technologies SG (ALRTF) has 4 years of Equity Ratio data on file, last reported at 841.36 in Q4 2025.

  • For the quarter ending Q4 2025, Equity Ratio fell 84.59% year-over-year to 841.36; the trailing twelve-month figure through Dec 2025 stood at 841.36 (down 84.59% YoY), and the FY2025 full-year result was 841.36, down 84.59% from the prior year.
  • Equity Ratio for Q4 2025 stood at 841.36, up from 1236.63 in the prior quarter.
  • Across five years, Equity Ratio topped out at 125.83 in Q4 2021 and bottomed at 1236.63 in Q2 2025.
  • The 4-year median for Equity Ratio is 599.77 (2024), against an average of 601.5.
  • The widest annual swing landed in 2024, when Equity Ratio plunged 121.64%; it then sank 66.27% in 2025.
  • A 4-year view of Equity Ratio shows it stood at 125.83 in 2021, then sank by 63.44% to 205.65 in 2023, then slumped by 121.64% to 455.8 in 2024, then plunged by 84.59% to 841.36 in 2025.
  • The last three Equity Ratio figures came in at 841.36 (Q4 2025), 1236.63 (Q2 2025), and 455.8 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.47
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.50
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.54
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.59
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.78
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.45
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.29
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.67
10 ALR Technologies SG - - - -841.36

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -841.36
Jun 30, 2025 -1,236.63
Dec 31, 2024 -455.80
Jun 30, 2024 -743.73
Dec 31, 2023 -205.65
Dec 31, 2021 -125.83